Logo Logo
[höher] Eine Ebene höher
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2011 | 2007 | 2005 | 1994 | 1993 | 1992 | 1991 | 1990 | 1988
Anzahl der Publikationen: 48

2023

Thienel, Manuela ORCID logoORCID: https://orcid.org/0000-0002-2471-5807; Müller-Reif, Johannes B. ORCID logoORCID: https://orcid.org/0000-0003-3454-2396; Zhang, Zhe ORCID logoORCID: https://orcid.org/0000-0002-1163-7897; Ehreiser, Vincent ORCID logoORCID: https://orcid.org/0000-0002-8820-8839; Huth, Judith; Shchurovska, Khrystyna; Kilani, Badr ORCID logoORCID: https://orcid.org/0000-0003-0230-094X; Schweizer, Lisa ORCID logoORCID: https://orcid.org/0000-0002-1165-7804; Geyer, Philipp E. ORCID logoORCID: https://orcid.org/0000-0001-7980-4826; Zwiebel, Maximilian ORCID logoORCID: https://orcid.org/0000-0002-7005-5619; Novotny, Julia ORCID logoORCID: https://orcid.org/0000-0002-0929-0273; Lüsebrink, Enzo ORCID logoORCID: https://orcid.org/0000-0002-3214-5672; Little, Gemma ORCID logoORCID: https://orcid.org/0000-0001-9810-4358; Orban, Martin ORCID logoORCID: https://orcid.org/0000-0001-9830-1941; Nicolai, Leo ORCID logoORCID: https://orcid.org/0000-0003-0776-5885; El Nemr, Shaza ORCID logoORCID: https://orcid.org/0000-0003-4542-693X; Titova, Anna ORCID logoORCID: https://orcid.org/0009-0005-7412-7447; Spannagl, Michael; Kindberg, Jonas ORCID logoORCID: https://orcid.org/0000-0003-1445-4524; Evans, Alina L. ORCID logoORCID: https://orcid.org/0000-0003-0513-4887; Mach, Orpheus ORCID logoORCID: https://orcid.org/0000-0002-7092-7050; Vogel, Matthias ORCID logoORCID: https://orcid.org/0009-0002-1563-4519; Tiedt, Steffen ORCID logoORCID: https://orcid.org/0000-0002-8817-8457; Ormanns, Steffen ORCID logoORCID: https://orcid.org/0000-0002-0754-9034; Kessler, Barbara; Dueck, Anne ORCID logoORCID: https://orcid.org/0000-0002-7956-6327; Friebe, Andrea; Jørgensen, Peter Godsk ORCID logoORCID: https://orcid.org/0000-0002-1217-8944; Majzoub-Altweck, Monir; Blutke, Andreas; Polzin, Amin ORCID logoORCID: https://orcid.org/0000-0002-5891-9672; Stark, Konstantin; Kääb, Stefan ORCID logoORCID: https://orcid.org/0000-0001-8824-3581; Maier, Doris ORCID logoORCID: https://orcid.org/0000-0002-3261-2381; Gibbins, Jonathan M.; Limper, Ulrich ORCID logoORCID: https://orcid.org/0000-0001-9927-4180; Frobert, Ole ORCID logoORCID: https://orcid.org/0000-0002-5846-345X; Mann, Matthias ORCID logoORCID: https://orcid.org/0000-0003-1292-4799; Massberg, Steffen ORCID logoORCID: https://orcid.org/0000-0001-7387-3986 und Petzold, Tobias ORCID logoORCID: https://orcid.org/0000-0001-7805-5632 (2023): Immobility-associated thromboprotection is conserved across mammalian species from bear to human. In: Science, Bd. 380, Nr. 6641: S. 178-187

2022

Johnson, Lisa M.; Spannagl, Michael; Wojtalewicz, Nathalie und Durner, Jürgen (2022): Comparison of fecal calprotectin and pancreatic elastase assays based on proficiency testing results. In: Clinical Biochemistry, Bd. 107: S. 19-23

Scherer-Buric, Regina A.; Lesser-Wetzold, Kornelia; Nagel, Dorothea; Weigand, Michael; Spannagl, Michael; Teupser, Daniel und Brügel, Mathias (2022): Performance testing of four automated coagulation analyzers in a university hospital setting with focus on global coagulation assays. In: International Journal of Laboratory Hematology, Bd. 44, Nr. 3: S. 643-653

2021

Duan, Rundan; Goldmann, Luise; Brandl, Richard; Spannagl, Michael; Weber, Christian; Siess, Wolfgang und Hundelshausen, Philipp von (24. September 2021): Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time. In: Frontiers in Cardiovascular Medicine, Bd. 8, 749022 [PDF, 2MB]

Pekrul, Isabell; Pfrepper, Christian; Calatzis, Geli; Giebl, Andreas; Siegemund, Annelie; Grützner, Stefanie und Spannagl, Michael (2021): Approximation of emicizumab plasma levels in emergency situations. A practical approach. In: Haemophilia, Bd. 27, Nr. 2, E214-E220

Kragh, Thorsten; Pekrul, Isabell; Ott, Helmut W.; Spannagl, Michael und Möhnle, Patrick (2021): A novel approach to laboratory assessment and reporting of platelet von Willebrand factor. In: Platelets, Bd. 33, Nr. 2: S. 242-248

2020

Petzold, Tobias; Thienel, Manuela; Dannenberg, Lisa; Mourikis, Philipp; Helten, Carolin; Ayhan, Aysel; M'Pembele, Rene; Achilles, Alina; Trojovky, Kajetan; Konsek, Daniel; Zhang, Zhe; Regenauer, Ron; Pircher, Joachim; Ehrlich, Andreas; Luesebrink, Enzo; Nicolai, Leo; Stocker, Thomas J.; Brandl, Richard; Roeschenthaler, Franz; Strecker, Jan; Saleh, Inas; Spannagl, Michael; Mayr, Christoph H.; Schiller, Herbert B.; Jung, Christian; Gerdes, Norbert; Hoffmann, Till; Levkau, Bodo; Hohlfeld, Thomas; Zeus, Tobias; Schulz, Christian; Kelm, Malte und Polzin, Amin (2020): Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1. In: Circulation Research, Bd. 126, Nr. 4: S. 486-500

Peyvandi, Flora; Kenet, Gili; Pekrul, Isabell; Pruthi, Rajiv K.; Ramge, Peter und Spannagl, Michael (2020): Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays. In: Journal of Thrombosis and Haemostasis (JTH), Bd. 18, Nr. 6: S. 1242-1255 [PDF, 879kB]

2019

Ney, Ludwig und Spannagl, Michael (2019): Gerinnungsprobleme in der Intensivmedizin – Update 2019. In: Transfusionsmedizin, Bd. 9, Nr. 1: S. 45-65

Goldmann, Luise; Duan, Rundan; Kragh, Thorsten; Wittmann, Georg; Weber, Christian; Lorenz, Reinhard; Hundelshausen, Philipp von; Spannagl, Michael und Siess, Wolfgang (2019): Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT? In: Blood Advances, Bd. 3, Nr. 23: S. 4021-4033

Nowak-Goettl, Ulrike; Miesbach, Wolfgang; Koscielny, Jürgen; Dempfle, Carl-Erik; Maegele, Marc; Depka Prondzinski, Mario von; Westrup, Dagmar und Spannagl, Michael (2019): Replacement Therapy in Patients with Von Willebrand Disease-Indications and Monitoring. In: Hamostaseologie, Bd. 39, Nr. 4: S. 326-338

Müller, Jens; Pekru, Isabell; Poetzsch, Bernd; Berning, Beate; Oldenburg, Johannes und Spannagl, Michael (2019): Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A. In: Thrombosis and Haemostasis, Bd. 119, Nr. 9: S. 1384-1393

Denzinger, Viola; Busygina, Kristina; Jamasbi, Janina; Pekrul, Isabell; Spannagl, Michael; Weber, Christian; Lorenz, Reinhard und Siess, Wolfgang (2019): Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib. In: Thrombosis and Haemostasis, Bd. 119, Nr. 3: S. 397-406

Pekrul, Isabell; Kragh, Thorsten; Turecek, Peter L.; Novack, Aaron R.; Ott, Helmut W. und Spannagl, Michael (2019): Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer. In: Platelets, Bd. 30, Nr. 2: S. 264-270

Moehnle, Patrick; Pekrul, Isabell; Spannagl, Michael; Sturm, Andreas; Singh, Delila und Dechant, Claudia (2019): Emicizumab in the Treatment of Acquired Haemophilia: A Case Report. In: Transfusion Medicine and Hemotherapy, Bd. 46, Nr. 2: S. 121-123

2018

Arakawa, Akiko; Vollmer, Sigrid; Besgen, Petra; Galinski, Adrian; Summer, Burkhard; Kawakami, Yoshio; Wollenberg, Andreas; Dornmair, Klaus; Spannagl, Michael; Ruzicka, Thomas; Thomas, Peter und Prinz, Jörg C. (2018): Unopposed IL-36 Activity Promotes Clonal CD4(+) T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis. In: Journal of Investigative Dermatology, Bd. 138, Nr. 6: S. 1338-1347

Bietenbeck, Andreas; Geilenkeuser, Wolf J.; Klawonn, Frank; Spannagl, Michael; Nauck, Matthias; Petersmann, Astrid; Thaler, Markus A.; Winter, Christof und Luppa, Peter B. (2018): External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impact. In: Clinical Chemistry and Laboratory Medicine, Bd. 56, Nr. 8: S. 1238-1250

Kellermair, Jörg; Ott, Helmut W.; Spannagl, Michael; Tomasits, Josef; Kammler, Jürgen; Blessberger, Hermann; Reiter, Christian und Steinwender, Clemens (2018): Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis. In: Clinical and Applied Thrombosis-Hemostasis, Bd. 24, Nr. 3: S. 496-501 [PDF, 355kB]

2017

Durner, Jürgen und Spannagl, Michael (2017): New perspectives on existing data in comparative measurements: a simple extension of the regression analysis. In: Clinical Chemistry and Laboratory Medicine, Bd. 55, Nr. 11, E254-E258

Frietsch, Thomas; Thomas, Daffyd; Schöler, Michael; Fleiter, Birgit; Schipplick, Martin; Spannagl, Michael; Knels, Ralf und Nguyen, Xuan (2017): Administration Safety of Blood Products - Lessons Learned from a National Registry for Transfusion and Hemotherapy Practice. In: Transfusion Medicine and Hemotherapy, Bd. 44, Nr. 4: S. 240-254

Black, Anne; Heimerl, Susanne; Oertli, Linnea; Wilczek, Wolf; Greinacher, Andreas; Spannagl, Michael; Herr, Wolfgang und Hart, Christina (2017): Implementation of a rapid HIT immunoassay at a university hospital Retrospective analysis of HIT laboratory orders in patients with thrombocytopenia. In: Thrombosis Research, Bd. 158: S. 65-70

Ziemann, Malte; Rink, Lothar; Frietsch, Thomas; Spannagl, Michael und Schuler, Ulrich (2017): Immunmodulation durch Transfusion von Erythrozytenkonzentraten. In: Transfusionsmedizin, Bd. 7, Nr. 1: S. 40-58

Koscielny, Jürgen; Heymann, Christian von; Zeymer, Uwe; Cremer, Jochen; Spannagl, Michael; Labenz, Joachim; Giannitsis, Evangelos und Goss, Franz (2017): Duale antithrombozytäre Therapie – Perioperativ absetzen oder weiterführen? In: Deutsche Medizinische Wochenschrift, Bd. 142, Nr. 16: S. 1223-1230

Blüm, Philipp; Pircher, Joachim; Merkle, Monika; Czermak, Thomas; Ribeiro, Andrea; Mannell, Hanna; Krötz, Florian; Hennrich, Alexander; Spannagl, Michael; Köppel, Simone; Gaitzsch, Erik und Wörnle, Markus (2017): Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C. In: Cellular & Molecular Immunology, Bd. 14, Nr. 12: S. 986-996

2016

Maegele, Marc; Grottke, Oliver; Schöchl, Herbert; Sakowitz, Oliver; Spannagl, Michael und Koscielny, Juergen (2016): Direct Oral Anticoagulants in Emergency Trauma Admissions Perioperative Management, and Handling Hemorrhage. In: Deutsches Ärzteblatt international, Bd. 113, Nr. 35-36: S. 575-582

2014

Raziorrouh, Bijan; Heeg, Malte; Kurktschiev, Peter; Schraut, Winfried; Zachoval, Reinhart; Wendtner, Clemens; Wächtler, Martin; Spannagl, Michael; Denk, Gerald; Ulsenheimer, Axel; Bengsch, Bertram; Pircher, Hanspeter; Diepolder, Helmut M.; Grüner, Norbert H. und Jung, Maria-Christina (2014): Inhibitory Phenotype of HBV-Specific CD4⁺ T-Cells Is Characterized by High PD-1 Expression but Absent Coregulation of Multiple Inhibitory Molecules.
In: PLOS ONE 9(8), e105703 [PDF, 1MB]

Hart, Christina; Heindl, Bernhard; Spannagl, Michael und Lison, Susanne (2014): A standardized treatment regimen for patients with severe haemophilia A undergoing orthopaedic or trauma surgery: a single centre experience. In: Blood Coagulation & Fibrinolysis, Bd. 26, Nr. 4: S. 396-402 [PDF, 239kB]

2013

Spannagl, Michael; Melzer, Nima; Bramlage, Peter; Englert, Cornelia und Eisele, Ralf (Januar 2013): Prospective, Non-interventional Study on the Real-World Use of Certoparin in Daily Practice-The PROMEMBER Study. In: Clinical and Applied Thrombosis-Hemostasis, Bd. 19, Nr. 1: S. 86-91 [PDF, 223kB]

Dübgen, Sebastian; Dicker, Andrea; Marschall, Christoph und Spannagl, Michael (2013): Gerinnungsphysiologische und genetische diagnostik bei hereditärem protein S-mangel/Coagulation testing and genetic diagnostics in hereditary protein S deficiency. In: Laboratoriumsmedizin - Journal of Laboratory Medicine, Bd. 37, Nr. 2: S. 79-89 [PDF, 821kB]

Ulsenheimer, Axel; Paranhos-Baccala, Glaucia; Komurian-Pradel, Florence; Raziorrouh, Bijan; Kurktschiev, Peter; Diepolder, Helmut M.; Zachoval, Reinhard; Spannagl, Michael; Jung, Maria-Christina und Grüner, Norbert H. (2013): Lack of variant specific CD8+T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C. In: Virology Journal 10:295 [PDF, 606kB]

2011

Sorensen, Benny; Spahn, Donat R.; Innerhofer, Petra; Spannagl, Michael und Rossaint, Rolf (2011): Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity. In: Critical Care 15:201 [PDF, 237kB]

Sorensen, Benny; Spahn, Donat R.; Innerhofer, Petra; Spannagl, Michael und Rossaint, Rolf (2011): Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity (vol 15, pg 201, 2011). In: Critical Care 15:409 [PDF, 106kB]

2007

Wittmann, Georg; Frank, Josef; Schramm, Wolfgang und Spannagl, Michael (2007): Automation and data processing with the immucor Galileo (R) system in a university blood bank. In: Transfusion Medicine and Hemotherapy, Nr. 5: S. 347-352 [PDF, 212kB]

2005

Klein, Christoph L.; Marki-Zay, János; Corbisier, Philippe; Gancberg, David; Cooper, S.; Gemmati, Donato; Halbmayer, Walter-Michael; Kitchen, Steve; Melegh, Béla; Neumaier, Michael; Oldenburg, Johannes; Opplinger Leibundgut, Elisabeth; Reitsma, Pieter H.; Rieger, Sandra; Schimmel, Heinz G.; Spannagl, Michael; Tordai, Attilia; Tosetto, Alberto; Visvikis, Sophie; Zadro, Renata und Mannhalter, Christine (2005): Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation. In: Clinical Chemistry and Laboratory Medicine, Bd. 43, Nr. 8: S. 862-868 [PDF, 284kB]

1994

Siebeck, Matthias; Cheronis, J. C.; Fink, Edwin; Kohl, Jacek; Spies, Bernd; Spannagl, Michael; Jochum, Marianne und Fritz, Hans (1994): Dextran sulfate activates the contact system and mediates arterial hypotension via B2 kinin receptors. In: Journal of applied physiology, Bd. 77: S. 2675-2680 [PDF, 1MB]

Siebeck, Matthias; Cheronis, John C.; Fink, Edwin; Kohl, Jacek; Spies, Bernd; Spannagl, Michael; Jochum, Marianne und Fritz, Hans (1994): Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. In: Journal of Applied Physiology, Bd. 77, Nr. 6: S. 2675-2680 [PDF, 1MB]

1993

Siebeck, Matthias; Fink, Edwin; Weipert, Joachim; Jochum, Marianne; Fritz, Hans; Spannagl, Michael; Kroworsch, Peter; Shimamoto, Kazuaki und Schweiberer, Leonhard (Februar 1993): Inhibition of Plasma Kallikrein with Aprotinin in porcine endotoxin Shock. In: The Journal of Trauma-Injury Infection & Critical Care, Bd. 34, Nr. 2: S. 193-198 [PDF, 1MB]

Dietrich, W.; Mossinger, H.; Spannagl, Michael; Jochum, Marianne; Wendt, P.; Baranky, A.; Meisner, H und Richter, J. A. (1993): Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. In: Journal of vascular surgery, Bd. 105: S. 712-720 [PDF, 7MB]

Nast-Kolb, Dieter; Waydhas, Christian; Kerim-Sade, C.; Jochum, Marianne und Spannagl, Michael (1993): Venöse Thrombosen nach schweren Mehrfachverletzungen. In: Der Orthopäde, Bd. 22: S. 110-116 [PDF, 1MB]

Nast-Kolb, Dieter; Waydhas, Christian; Jochum, Marianne; Spannagl, Michael; Machleidt, W.; Duswald, Karl-Heimo und Schweiberer, Leonhard (1993): Diagnostic role of new mediators and markers of inflammation in multiple injured patients. In: Faist, E.; Meakins, J. und Schildberg, F. W. (Hrsg.): Host Defence Dysfunction in Trauma, Shock and Sepsis. Berlin, Heidelberg: Springer. S. 221-227 [PDF, 1MB]

1992

Nast-Kolb, Dieter; Waydhas, Christian; Jochum, Marianne; Duswald, Karl-Heimo; Machleidt, W.; Spannagl, Michael; Schramm, Wolfgang; Fritz, Hans und Schweiberer, Leonhard (1992): Biochemische Faktoren als objektive Parameter zur Prognoseabschätzung beim Polytrauma. In: Der Unfallchirurg, Bd. 95, Nr. 2: S. 59-66 [PDF, 1MB]

Siebeck, Matthias; Spannagl, Michael; Hoffmann, H. und Fink, Edwin (1992): Effects of protease inhibitors in experimental septic shock. International Conference "Kinin 91 Munich, München, 8. - 14. September 1991. International Conference Kinin (Hrsg.), In: Recent Progress on Kinins, Agents and actions Suppl. Bd. 38/III S. 421-427 [PDF, 505kB]

1991

Dietrich, W.; Spannagl, Michael; Jochum, Marianne; Wendt, P.; Baranky, A. und Richter, J. A. (1991): Investigation on the mechanisms of action of aprotinin in cardiac surgery. In: Friedel, N.; Hetzer, P. und Royston, D. (Hrsg.): Blood Use in Cardiac Surgery. Darmstadt: Steinkopff. S. 232-239 [PDF, 1MB]

1990

Spannagl, Michael; Schiffl, H.; Hoffmann, H. und Jochum, Marianne (1990): Hemodialysis membrane-related neutrophil dysfunctions and pentoxifylline - a pilot study. In: Klinische Wochenschrift, Bd. 68, Nr. 18: S. 901-905 [PDF, 526kB]

Nast-Kolb, Dieter; Waydhas, Christian; Jochum, Marianne; Spannagl, Michael; Duswald, Karl-Heimo und Schweiberer, Leonhard (1990): Günstigster Operationszeitpunkt für die Versorgung von Femurschaftfrakturen beim Polytrauma? In: Der Chirurg, Bd. 61: S. 259-265 [PDF, 1MB]

Hoffmann, H.; Siebeck, Matthias; Spannagl, Michael; Weipert, J.; Geiger, R.; Jochum, Marianne und Fritz, Hans (1990): Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. In: American review of respiratory diseases, Bd. 142, Nr. 4: S. 782-788 [PDF, 1MB]

Dietrich, W.; Spannagl, Michael; Jochum, Marianne; Wendt, P.; Schramm, Wolfgang; Baranky, A. und Sebening, F. (1990): Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in open-heart surgery. In: Anesthesiology, Bd. 73: S. 1119-1126 [PDF, 2MB]

1988

Dietrich, W.; Baranky, A.; Wendt, P.; Sternberger, A.; Blümel, G.; Spannagl, Michael; Jochum, Marianne und Richter, J. A. (1988): Fibrinolysis caused by cardio-pulmonary bypass and shed mediastinal blood retransfusion. Is it of clinical relevance? In: Hörl, Walter H. und Heidland, A. (Hrsg.): Proteases. Potential Role in Health and Disease. Bd. 2. New York: Plenum Press. S. 405-410 [PDF, 984kB]

Diese Liste wurde am Sat Dec 21 18:11:40 2024 CET erstellt.

Open Access LMU verwendet EPrints 3, das an der School of Electronics and Computer Science der Universität Southampton entwickelt wurde.
Impressum − Datenschutz